NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 49 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $10,605,000 | -2.9% | 364,800 | +1.2% | 0.23% | -0.4% |
| Q4 2020 | $10,921,000 | +90.4% | 360,500 | +0.0% | 0.23% | +58.9% |
| Q3 2020 | $5,735,000 | -18.7% | 360,454 | +0.9% | 0.15% | -24.7% |
| Q2 2020 | $7,055,000 | +63.0% | 357,409 | +1.8% | 0.19% | +8.4% |
| Q1 2020 | $4,329,000 | -33.3% | 351,100 | 0.0% | 0.18% | -12.7% |
| Q4 2019 | $6,492,000 | +33.5% | 351,100 | 0.0% | 0.20% | +5.7% |
| Q3 2019 | $4,863,000 | -5.4% | 351,100 | 0.0% | 0.19% | +4.3% |
| Q2 2019 | $5,140,000 | – | 351,100 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 18,136,735 | $237,228,000 | 52.50% |
| Ponoi II Management, LLC | 1,298,908 | $16,990,000 | 44.41% |
| Ponoi Management, LLC | 1,298,908 | $16,990,000 | 23.20% |
| Euclidean Capital LLC | 746,674 | $9,766,000 | 9.07% |
| StepStone Group LP | 1,573,357 | $20,580,000 | 2.93% |
| Logos Global Management LP | 850,000 | $11,118,000 | 1.37% |
| First Light Asset Management, LLC | 955,505 | $12,498,000 | 1.26% |
| GREAT POINT PARTNERS LLC | 316,256 | $4,137,000 | 1.00% |
| Rubric Capital Management LP | 877,161 | $11,473,000 | 0.58% |
| Avidity Partners Management LP | 1,798,100 | $23,519,000 | 0.48% |